AVO Aveon Group LP Com USD0.01

Advanced Medical Optics Announces Effectiveness of Registration Statement on Form S-3 SANTA ANA, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE:AVO) today announced that its registration statement on Form S-3 relating to resales by securityholders of the company's issued and outstanding 2.50% Convertible Senior Subordinated Notes due 2024, and the shares of its common stock issuable upon conversion of the Notes, was declared effective by the Securities and Exchange Commission. A copy of the prospectus may be obtained from Investor Relations, Advanced Medical Optics, Inc., 1700 E. St. Andrew Place, Santa Ana, CA 92705. The registration statement was filed on behalf of the selling security holders, and AMO will not receive any proceeds from the resale of the Notes or the underlying common stock. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any State in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such State. About Advanced Medical Optics Advanced Medical Optics, Inc. (AMO) is a global leader in the development, manufacturing and marketing of ophthalmic surgical and eye care products. The company focuses on developing a broad suite of innovative technologies and devices to address a wide range of eye disorders. Products in the ophthalmic surgical line include intraocular lenses, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as Phacoflex(R), Clariflex(R), Array(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(TM) technology, Amadeus(TM) microkeratome, Healon(R) and Vitrax(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 2,800 worldwide. The company has operations in about 20 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at http://www.amo-inc.com/. For further information please contact: Sheree Aronson of Advanced Medical Optics, Inc., +1-714-247-8290, DATASOURCE: Advanced Medical Optics, Inc. CONTACT: Sheree Aronson of Advanced Medical Optics, Inc., +1-714-247-8290, Web site: http://www.amo-inc.com/

Copyright